Scholarly Index
Timothy M. Bahr
Intermountain Healthcare; 1,003 total citations; 98 total publications; best world rank #16
Intermountain Healthcare
1,003Total citations
98Total publications
15H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Methemoglobinemia and Tumor Lysis Syndrome | Lifetime | 278 | US 113 | 83.58 |
| Neonatal Health and Biochemistry | 2021-2025 | 16 | US 7 | 96.43 |
| Hemoglobinopathies and Related Disorders | 2021-2025 | 143 | US 69 | 95.98 |
| Neonatal Respiratory Health Research | 2021-2025 | 445 | US 151 | 94.59 |
| Blood groups and transfusion | 2021-2025 | 155 | US 54 | 92.85 |
| Iron Metabolism and Disorders | 2021-2025 | 250 | US 100 | 92.03 |
| Heme Oxygenase-1 and Carbon Monoxide | 2021-2025 | 163 | US 40 | 85.28 |
| Erythrocyte Function and Pathophysiology | 2021-2025 | 278 | US 94 | 85.63 |
| Neonatal and fetal brain pathology | 2021-2025 | 626 | US 201 | 85.27 |
| Methemoglobinemia and Tumor Lysis Syndrome | 2021-2025 | 23 | US 7 | 78.28 |
| Hyperglycemia and glycemic control in critically ill and hospitalized patients | 2021-2025 | 492 | US 184 | 72.53 |
| Blood transfusion and management | 2021-2025 | 577 | US 231 | 68.67 |